Showing results (41-50 of 96) with videos related to

Sort By:
Pageof 10
The Lancet Regional Health. Europe|October 27, 2025
Type 2 diabetes remission after initiation of GLP-1 receptor agonists: frequency, characteristics, and outcomes using multiple definitions in an observational studyGian Paolo Fadini, Andrea Giaccari, Fabio Broglio, et al.
Diabetes, Obesity & Metabolism|February 8, 2024
IDegLira for the real-world treatment of type 2 diabetes in Italy. Final results from the REX observational studyGian Paolo Fadini, Raffaella Buzzetti, Dario Pitocco, et al.
Diabetes/Metabolism Research and Reviews|July 29, 2017
Liraglutide mitigates TNF-α induced pro-atherogenic changes and microvesicle release in HUVEC from diabetic womenPamela Di Tomo, Paola Lanuti, Natalia Di Pietro, et al.
Diabetes Research and Clinical Practice|January 20, 2009
Novel mutations in GCK and HNF1A genes in Italian families with MODY phenotypeAlessia Cappelli, Stefano Tumini, Agostino Consoli, et al.
Ophthalmic Epidemiology|January 21, 2020
Why Miss the Chance? Incidental Findings while Telescreening for Diabetic RetinopathyLeonardo Mastropasqua, Roberto Perilli, Rossella D'Aloisio, et al.
Free Radical Biology & Medicine|July 21, 2007
Soluble RAGE in type 2 diabetes: association with oxidative stressEleonora Devangelio, Francesca Santilli, Gloria Formoso, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|August 13, 2023
Continuous glucose monitoring (CGM) in a non-Icu hospital setting: The patient's journeyConcetta Irace, Sara Coluzzi, Graziano Di Cianni, et al.
Journal of Cellular Biochemistry|October 18, 2005
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) regulates endothelial nitric oxide synthase (eNOS) activity and its localization within the human vein endothelial cells (HUVEC) in cultureRoberta Di Pietro, Maria A Mariggiò, Simone Guarnieri, et al.
Journal of the American Heart Association|July 20, 2014
Circulating dickkopf-1 in diabetes mellitus: association with platelet activation and effects of improved metabolic control and low-dose aspirinStefano Lattanzio, Francesca Santilli, Rossella Liani, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 18, 2022
IDegLira for the Real-World Treatment of Type 2 Diabetes in Italy: Protocol and Interim Results from the REX Observational StudyGian Paolo Fadini, Raffaella Buzzetti, Maria Rosa Fittipaldi, et al.
Pageof 10